All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

30

Reset

30 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SintilimabIBI308Phase 321 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Hepatocellular Carcinoma, Solid Tumor, HCC - Hepatocellular Carcinoma

  • IBI362Phase 38 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Obesity, Overweight, Sleep Apnea

  • Tegafur-gimeracil-oteracil potassiumS-1, tegafurPhase 38 trials

    Ono Pharmaceutical Co., Ltd. · Gastric Cancer, Esophageal Cancer, Resectable Gastric/Gastroesophageal Junction Adenocarcinoma

  • TelitaciceptRC18, RC18-LPhase 38 trials

    RemeGen Co., Ltd. · CTD-ILD, Primary Sjogren's Disease, Sjögren's Disease

  • IBI363Phase 37 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Melanoma, Colorectal Cancer, Resectable Stage II-III Non-small Cell Lung Cancer

  • RAY1225Phase 35 trials

    Guangdong Raynovent Biotech Co., Ltd · Obesity, T2DM, T2DM (Type 2 Diabetes Mellitus)

  • IBI3003Phase 34 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma

  • IBI343Arcotatug TavatecanPhase 34 trials

    Innovent Biologics (Suzhou) Co. Ltd. · CLDN18.2 Positive, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Primary Gastric Adenocarcinoma

  • IBI311Phase 33 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Thyroid Eye Disease, Thyroid Eye Disease, TED

  • IBI354Phase 33 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors, Ovarian, Primary Peritoneal

  • LimertinibPhase 33 trials

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive

  • Oteracil Potassiumgimeracil], S-1 [TegafurPhase 33 trials

    AstraZeneca · Biliary Tract Cancer, Resectable Gastric/Gastroesophageal Junction Adenocarcinoma, Malignant Neoplasms of Digestive Organs

  • TigulixostatIBI128, LC350189Phase 33 trials

    Innovent Biologics Technology Limited (Shanghai R&D Center) · Gout, Hyperuricemia, Gout Flare

  • IBI112Phase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriasis

  • IBI302Phase 32 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Neovascular Age-related Macular Degeneration, Diabetic Macular Oedema

  • IBI310Phase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma

  • PicankibartPhase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis

  • ZSP1273Phase 32 trials

    Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a

  • IBI3027Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • IBI306Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

  • IBI129Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

  • IBI133Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors

  • IBI3002Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • IBI3005Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

  • IBI3014Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Unresectable Locally Advanced or Metastatic Solid Tumors

  • IBI3016Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Hypertension

  • IBI305Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer

  • IBI334Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Advanced Solid Tumors

  • IBI355Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Sjögren's Disease

  • ZSP1601Phase 21 trial

    Guangdong Raynovent Biotech Co., Ltd · Nonalcoholic Steatohepatitis (NASH)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.